Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.
about
Plasmatic level of neurosin predicts outcome of mild cognitive impairment.Effects of Ginkgo biloba in dementia: systematic review and meta-analysisRole of imaging techniques in the diagnosis of dementiaObesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysisOmega-3 fatty acids for the treatment of dementiaMontreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementiasMini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populationsStatin withdrawal in people with dementiaRegional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementiaInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care settingMini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care settingMini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingOmega 3 fatty acids for the treatment of dementiaMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingEnvironmental and behavioural modifications for improving food and fluid intake in people with dementiaInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settingsPlasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s dementia and other dementias in asymptomatic and previously clinically unevaluated people aged over 65 years in community and primary care populations11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingAD-8 for diagnosis of dementia across a variety of healthcare settingsInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populationsMini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) settingIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingNeuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesCholinesterase inhibitors for mild cognitive impairmentIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care settingCerebrolysin for vascular dementiaTraditional Chinese herbal medicine for vascular dementiaHyperbaric oxygen therapy for vascular dementiarCBF SPECT for detection of frontotemporal dementia in people with suspected dementiaCognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementiaMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingRivastigmine for vascular cognitive impairmentThe role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)
P2860
Q21202048-2B266B91-5A64-4A76-9404-84C540B1CFCCQ21261865-6BAA9B5B-CF93-498F-A3FC-6EFF5E6D8333Q22241579-C32FE43D-7105-4501-A6F0-BFD157AECF8CQ22242405-69576EC3-B2C5-4893-8FE7-E35633C8A896Q24185910-4BA2C648-6FA6-4EB7-8E84-B41248CE7D6BQ24186280-FB3548F2-3503-498A-89A7-0B4CDA333808Q24186302-A107A475-65B0-4577-9BD4-119CDC488CEEQ24186720-79FFBB92-4D43-47B5-B419-5415408B1D97Q24186916-68DC66B7-84DF-4B50-886B-D93100438112Q24187059-ECD463E1-F60A-44CC-9ED3-86AB87A08CA4Q24187527-738999DB-0144-4F35-A36E-A749F9783F71Q24187538-D2EB32E7-106D-4D5B-BA7C-87DBD58DF800Q24187713-B8AA6496-69D7-4F50-AEAE-C724612A929EQ24187908-9D83D78F-EF9F-4453-85EC-03FF52F2A913Q24188315-09B51E9D-5E1A-443A-AE3B-F27B58DE6FC9Q24193211-16A97536-2C28-47D0-B6B8-59FC98BE13ECQ24193707-C1B6FC43-95AF-4849-8596-1EF1500F4A56Q24194186-2B785EE8-A2DB-4A8F-BB32-13140BF15ACEQ24194742-E51D2C5E-870D-4598-9A07-CB0A883AA4C0Q24194747-0A41C2DC-8E03-4A65-9FC1-E1CB7C697481Q24194796-FEADBAF3-7D6A-48C2-A689-B5A7CB63F5CFQ24194962-4CA1DC6C-863F-4703-A8E6-A9A617D7583EQ24197659-BF65B37C-013D-47BD-85E5-F13B42D72BFCQ24197665-DCEEFDE6-F5D3-4C95-856E-735DFDCDEADDQ24197672-2A94ABFD-61E0-4C55-8618-51285AAB234CQ24200257-95D84045-DD80-4204-BD24-31F5BD09AC53Q24200430-C664118E-606A-4DE8-AE69-935809430368Q24200918-E974B0B6-CE57-42BC-ACD5-1BBCA9C0DB97Q24201039-D6F198B1-2650-47A6-90C0-229AF1D853CBQ24201260-0A703D41-29FF-43E4-977A-4511A9B1BAC3Q24201265-3A05F4CB-21CB-4F16-B6DC-F819CD4D643AQ24201271-81D4BA9D-66B0-4E74-9282-251E29DB92D8Q24201712-BE4F22C2-CFAD-4905-A6A3-C297E9548A21Q24201976-48F38ED5-1D08-4043-9F2A-F2E500F5DD81Q24202011-97F5291F-9F75-4AB8-B26D-D5312D736C57Q24202037-9A81264D-2C9F-4136-816A-5B2856094998Q24202225-17580DF8-4759-4F07-892E-0C3353F16AF5Q24202610-22CD0F84-E77F-4EBF-B87A-48DAFAEC2A29Q24202891-AD99209F-9260-45A2-939E-5906FE7DD230Q24203748-CEDF42ED-B234-4298-BF25-F5831508345E
P2860
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@en
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@nl
type
label
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@en
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@nl
prefLabel
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@en
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@nl
P2093
P356
P1433
P1476
Vascular dementia: diagnostic ...... -AIREN International Workshop.
@en
P2093
Amaducci L
Cummings JL
Erkinjuntti T
Orgogozo JM
Tatemichi TK
P304
P356
10.1212/WNL.43.2.250
P407
P577
1993-02-01T00:00:00Z